AEX-5

N/A

Report date: 2024/03/14 17:26:10
NME

Base Information

Drug NameAEX-5
Drug Alias NameAEX-5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine reuptake inhibitorsCathepsins inhibitorsOrexin receptor type 1 agonists
TargetsDopamine transporterCathepsinsOrexin receptor type 1
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAexon Labs Inc
China Registration ClassN/A

Develop Information

Active CompaniesAexon Labs Inc
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A